Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00728754 · ClinicalTrials.gov registry record · NA
A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.
A NA study of Partial-edentulism and Tooth Disease, sponsored by ZimVie.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT00728754: Completed NA study of Partial-edentulism and Tooth Disease, sponsored by ZimVie.
NCT00728754 is a NA study of Partial-edentulism and Tooth Disease that has completed, run by ZimVie. The registered enrollment target is 61 participants, above the 51-participant average among 3 other Partial-edentulism trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00728754, a NA study of Partial-edentulism and Tooth Disease, has completed, sponsored by ZimVie.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective, randomized study will evaluate the performance of the Osseotite Certain Prevail implant when compared to that of the non-lateralized version of the implant. Study (null) hypothesis: the crestal bone changes that take place after placement and loading of the Osseotite lateralized implants will be the same as for a similar but non-lateralized Osseotite Certain implant.
Primary Outcome
Millimeters of crestal bone observed and measured in a radiograph of each study implant is measured and averaged to obtain the mean crestal bone loss or gain for each implant unit.
Conditions Studied
Interventions
- DEVICE Dental implant Osseotite Prevail
- DEVICE Dental implant Osseotite
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2005-03 |
| Est. Completion | 2011-04 |
| Phase | NA |
What the finished NCT00728754 record still lists
NCT00728754 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, above the 51-participant average among 3 other Partial-edentulism trials with a reported enrollment target (20% higher).
The record links to 2 conditions, with Partial-edentulism appearing as the primary indexed condition, and to 2 interventions - of which Dental implant Osseotite Prevail is the first listed.
NCT00728754 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00728754 about?
NCT00728754 is a clinical study titled "A Study of Certain Prevail Implants Used for the Preservation of Crestal Bone in Short Fixed Bridge Cases.". This prospective, randomized study will evaluate the performance of the Osseotite Certain Prevail implant when compared to that of the non-lateralized version of the implant. Study (null) hypothesis: the crestal bone changes that take place after placement and loading of the Osseotite lateralized i...
What is the current status of trial NCT00728754?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2005-03. Estimated completion is 2011-04.
What conditions does trial NCT00728754 study?
This clinical trial studies the following conditions: Partial-edentulism, Tooth Disease.
What interventions are being tested in trial NCT00728754?
The interventions under investigation include: Dental implant Osseotite Prevail (DEVICE), Dental implant Osseotite (DEVICE).
Who is sponsoring clinical trial NCT00728754?
This trial is sponsored by ZimVie, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00728754 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Partial-edentulism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia